CIS treatment led to leukocyte accumulation and elevated MPO levels, leading to rat ovarian tissue congestion, oedema, and follicular degeneration (Atli et al., 2017; Mentese et al., 2022; Ciplak et al., 2023). Here, MPO is linked to in situ carcinoma.